Literature DB >> 26771303

Commercial Ethyl Glucuronide (EtG) and Ethyl Sulfate (EtS) Testing is Not Vulnerable to Incidental Alcohol Exposure in Pregnant Women.

Steven J Ondersma1, Jessica R Beatty2, Thomas G Rosano3, Ronald C Strickler4, Amy E Graham2, Robert J Sokol5.   

Abstract

BACKGROUND: Ethyl Glucoronide (EtG) and Ethyl Sulfate (EtS) have shown promise as biomarkers for alcohol and may be sensitive enough for use with pregnant women in whom even low-level alcohol use is important. However, there have been reports of over-sensitivity of EtG and EtS to incidental exposure to sources such as alcohol-based hand sanitizer. Further, few studies have evaluated these biomarkers among pregnant women, in whom the dynamics of these metabolites may differ.
OBJECTIVES: This study evaluated whether commercial EtG-EtS testing was vulnerable to high levels of environmental exposure to alcohol in pregnant women.
METHODS: Two separate samples of five nurses-one pregnant and the other postpartum, all of whom reported high levels of alcohol-based hand sanitizer use-provided urine samples before and 4-8 hours after rinsing with alcohol-based mouthwash and using hand sanitizer. The five pregnant nurses provided urine samples before, during, and after an 8-hour nursing shift, during which they repeatedly cleansed with alcohol-based hand sanitizer (mean 33.8 uses). The five postpartum nurses used hand sanitizer repeatedly between baseline and follow-up urine samples.
RESULTS: No urine samples were positive for EtG-EtS at baseline or follow-up, despite use of mouthwash and-in the pregnant sample-heavy use of hand sanitizer (mean of 33.8 uses) throughout the 8-hour shift. CONCLUSIONS/IMPORTANCE: Current, commercially available EtG-EtS testing does not appear vulnerable to even heavy exposure to incidental sources of alcohol among pregnant and postpartum women.

Entities:  

Keywords:  Ethyl glucuronide; alcohol-related neurodevelopmental disorder; ethyl sulfate; pregnancy; substance abuse detection/methods

Mesh:

Substances:

Year:  2016        PMID: 26771303      PMCID: PMC4832416          DOI: 10.3109/10826084.2015.1073324

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  20 in total

1.  Recommendations on use of biomarkers in alcoholism treatment trials.

Authors:  John P Allen; Raye Z Litten
Journal:  Alcohol Clin Exp Res       Date:  2003-10       Impact factor: 3.455

2.  Fetal alcohol spectrum disorder.

Authors:  Robert J Sokol; Virginia Delaney-Black; Beth Nordstrom
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

Review 3.  Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review.

Authors:  X Joya; B Friguls; S Ortigosa; E Papaseit; S E Martínez; A Manich; O Garcia-Algar; R Pacifici; O Vall; S Pichini
Journal:  J Pharm Biomed Anal       Date:  2012-01-16       Impact factor: 3.935

4.  Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers.

Authors:  Hicham Kharbouche; Mohamed Faouzi; Nathalie Sanchez; Jean Bernard Daeppen; Marc Augsburger; Patrice Mangin; Christian Staub; Frank Sporkert
Journal:  Int J Legal Med       Date:  2011-09-11       Impact factor: 2.686

5.  Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods--misleading results?

Authors:  Frank Musshoff; Elena Albermann; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-09-14       Impact factor: 2.686

Review 6.  A review of the use of ethyl glucuronide as a marker for ethanol consumption in forensic and clinical medicine.

Authors:  Robert B Palmer
Journal:  Semin Diagn Pathol       Date:  2009-02       Impact factor: 3.464

7.  Approaching the prevalence of the full spectrum of fetal alcohol spectrum disorders in a South African population-based study.

Authors:  Philip A May; Jason Blankenship; Anna-Susan Marais; J Phillip Gossage; Wendy O Kalberg; Ronel Barnard; Marlene De Vries; Luther K Robinson; Colleen M Adnams; David Buckley; Melanie Manning; Kenneth L Jones; Charles Parry; H Eugene Hoyme; Soraya Seedat
Journal:  Alcohol Clin Exp Res       Date:  2012-12-14       Impact factor: 3.455

8.  Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol.

Authors:  L Morini; E Marchei; F Vagnarelli; O Garcia Algar; A Groppi; L Mastrobattista; S Pichini
Journal:  Forensic Sci Int       Date:  2010-01-08       Impact factor: 2.395

9.  Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT--a pilot study in a population-based sample of Swedish women.

Authors:  Friedrich Martin Wurst; Erika Kelso; Wolfgang Weinmann; Fritz Pragst; Michel Yegles; Inger Sundström Poromaa
Journal:  Am J Obstet Gynecol       Date:  2008-01-25       Impact factor: 8.661

10.  Ethyl glucuronide excretion in humans following oral administration of and dermal exposure to ethanol.

Authors:  Thomas G Rosano; Jing Lin
Journal:  J Anal Toxicol       Date:  2008-10       Impact factor: 3.367

View more
  2 in total

1.  Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol.

Authors:  Steven J Ondersma; Lisa Todd; Samantha Jablonski; Chaarushi Ahuja; Kathryn Gilstad-Hayden; Gregory Goyert; Amy Loree; Jaimee Heffner; Kimberly A Yonkers
Journal:  BMJ Open       Date:  2022-08-03       Impact factor: 3.006

Review 2.  Fetal alcohol-spectrum disorders: identifying at-risk mothers.

Authors:  Annika C Montag
Journal:  Int J Womens Health       Date:  2016-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.